SOW
AQST icon

State of Wyoming’s Aquestive Therapeutics AQST Stock Holding History

State of Wyoming’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13K Buy
+753
New +$3.06K ﹤0.01% 1756
2025
Q1 		– Sell
-5,229
Closed -$18.6K – 1644
2024
Q4 		$18.6K Buy
+5,229
New +$24.1K ﹤0.01% 1524
2024
Q3 		– Sell
-13,176
Closed -$34.3K – 1685
2024
Q2 		$34.3K Buy
+13,176
New +$44K 0.01% 1469

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wyoming's AQST Position: Q1 2026 in Review

State of Wyoming opened a new position in Aquestive Therapeutics (AQST) in Q1 2026: 753 shares worth $3.13K. The stake represents ﹤0.01% of the portfolio and ranks #1756 among its holdings. This is a return to the name: State of Wyoming previously reported a position in AQST as recently as Q4 2024.

State of Wyoming first reported a position in AQST in Q2 2024 and has held it in 3 quarters since. The position peaked at $34.3K in Q2 2024. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • State of Wyoming held 753 shares of Aquestive Therapeutics worth $3.13K as of Q1 2026.
  • Aquestive Therapeutics was a new State of Wyoming position in Q1 2026.
  • Aquestive Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1756 holding.
  • State of Wyoming first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • State of Wyoming's Aquestive Therapeutics position peaked at $34.3K in Q2 2024.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.